Most people talk about healthcare innovation.
Few have built it across decades.
In our upcoming episode of Clinical Investment Insider, we sit down with Rose Satz, a Core Advisor Fellow inside the Health Board Advisors ecosystem.
With 30+ years of leading drug development, clinical translation, and commercialization, Rose brings rare insight from the front lines of biotech growth.
She has advised investors and healthcare companies on regulatory strategy, capital formation, and AI innovation.
Rose is now building an investment platform to scale transformative healthcare solutions and next-generation medical technologies globally.
Why this conversation matters:
👏 Learn what investors really look for in healthcare companies.
👏 Hear how biotech leaders think about growth and exits.
👏 Understand how regulation can become an advantage.
👏 See where AI is creating new healthcare opportunities.
👏 Discover what it takes to build companies that last.
Rose represents the kind of expert leadership we are proud to have inside HBA.
Real operators. Real builders. Real impact.
Our ecosystem is built on the Triple-Match model:
Founder ⇄ Clinician-Investor ⇄ Operator
Seed to Scale | We Guide. Match. Build, Together.
Stay tuned. The episode drops soon.
